Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium EDTA added to standard ICU care for patients with COVID-19
IRCT20210913052453N1Phase 3Completed
- Sponsor
- Asadabad University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of edetate calcium disodium in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Asadabad University of Medical Sciences. Primary endpoint: Improve oxygen supply. Started Sep 2021; status: completed.
02
Drugs
edetate calcium disodium
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210913052453N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210913052453N1.